FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2600620731> ?p ?o ?g. }

• W2600620731 abstract "Objective: To provide a rationale for the increasing use of ofloxacin as a substitute for ciprofloxacin, and to review the appropriate use of these agents. Data Source: A MEDLINE search was conducted to identify relevant literature. References in those articles were reviewed for additional published information. Study Selection: Published review articles and clinical trials on ofloxacin were reviewed, with particular emphasis on pharmacoeconomics, pharmacodynamics, and studies evaluating the safety and efficacy of ofloxacin. Data Synthesis: Ofloxacin is a broad-spectrum antimicrobial agent that has in vitro activity similar to that of ciprofloxacin. Ciprofloxacin exhibits lower minimum inhibitory concentrations for Pseudomonas aeruginoea, and ofloxacin is more active against Chlamydia trachomatis and gram-positive aerobic organisms. Both agents have limited anaerobic activity. Unlike ciprofloxacin, ofloxacin is 100% bioavailable, exhibits a greater area under the concentration curve, contributing to its bactericidal activity, and is eliminated primarily by the kidney. Both ciprofloxacin and ofloxacin have long half-lives, allowing twice-daily dosing. However, because a decrease in renal function often accompanies increasing age, ofloxacin can be administered once daily in the elderly. Both agents have a large volume of distribution and exhibit excellent tissue and cell penetration. Several clinical studies have demonstrated ofloxacin's effectiveness in treating a variety of systemic infections caused by susceptible organisms, including P. aeruginosa. Adverse effects are infrequent with both fluoroquinolones, and if they occur such effects are usually gastrointestinal in nature. Ofloxacin has a much lower incidence of drug interactions, in particular with theophylline and caffeine. Ofloxacin is less expensive than ciprofloxacin. Conclusions: Overall, the activity of ofloxacin is similar to that of ciprofloxacin and the two agents are therapeutically equivalent. The data presented warrant routine therapeutic substitution of ofloxacin for ciprofloxacin. Ciprofloxacin should be reserved for instances in which specific prescribing criteria are met." @default.
• W2600620731 created "2017-04-07" @default.
• W2600620731 creator A5012178380 @default.
• W2600620731 creator A5078547326 @default.
• W2600620731 date "1996-05-01" @default.
• W2600620731 modified "2023-09-27" @default.
• W2600620731 title "Meta-Analytic Review of the Effect of Subcutaneous Sumatriptan in Migraine Headache" @default.
• W2600620731 cites W1968234092 @default.
• W2600620731 cites W1969981038 @default.
• W2600620731 cites W1972621707 @default.
• W2600620731 cites W1972838073 @default.
• W2600620731 cites W1978365721 @default.
• W2600620731 cites W1981748818 @default.
• W2600620731 cites W1985762969 @default.
• W2600620731 cites W1990387364 @default.
• W2600620731 cites W2000538455 @default.
• W2600620731 cites W200563459 @default.
• W2600620731 cites W2007830665 @default.
• W2600620731 cites W2033173190 @default.
• W2600620731 cites W2055064537 @default.
• W2600620731 cites W2061923792 @default.
• W2600620731 cites W2063916204 @default.
• W2600620731 cites W2087030391 @default.
• W2600620731 cites W2132190941 @default.
• W2600620731 cites W2527558851 @default.
• W2600620731 cites W2410008476 @default.
• W2600620731 doi "https://doi.org/10.1177/875512259601200310" @default.
• W2600620731 hasPublicationYear "1996" @default.
• W2600620731 type Work @default.
• W2600620731 sameAs 2600620731 @default.
• W2600620731 citedByCount "2" @default.
• W2600620731 crossrefType "journal-article" @default.
• W2600620731 hasAuthorship W2600620731A5012178380 @default.
• W2600620731 hasAuthorship W2600620731A5078547326 @default.
• W2600620731 hasConcept C126322002 @default.
• W2600620731 hasConcept C16005928 @default.
• W2600620731 hasConcept C170493617 @default.
• W2600620731 hasConcept C2778541695 @default.
• W2600620731 hasConcept C2778871607 @default.
• W2600620731 hasConcept C2778938600 @default.
• W2600620731 hasConcept C42219234 @default.
• W2600620731 hasConcept C71924100 @default.
• W2600620731 hasConceptScore W2600620731C126322002 @default.
• W2600620731 hasConceptScore W2600620731C16005928 @default.
• W2600620731 hasConceptScore W2600620731C170493617 @default.
• W2600620731 hasConceptScore W2600620731C2778541695 @default.
• W2600620731 hasConceptScore W2600620731C2778871607 @default.
• W2600620731 hasConceptScore W2600620731C2778938600 @default.
• W2600620731 hasConceptScore W2600620731C42219234 @default.
• W2600620731 hasConceptScore W2600620731C71924100 @default.
• W2600620731 hasLocation W26006207311 @default.
• W2600620731 hasOpenAccess W2600620731 @default.
• W2600620731 hasPrimaryLocation W26006207311 @default.
• W2600620731 hasRelatedWork W1976977302 @default.
• W2600620731 hasRelatedWork W1986291953 @default.
• W2600620731 hasRelatedWork W1995484097 @default.
• W2600620731 hasRelatedWork W1996787686 @default.
• W2600620731 hasRelatedWork W2031844965 @default.
• W2600620731 hasRelatedWork W2039302050 @default.
• W2600620731 hasRelatedWork W2075114460 @default.
• W2600620731 hasRelatedWork W2092235823 @default.
• W2600620731 hasRelatedWork W2157637604 @default.
• W2600620731 hasRelatedWork W2398429995 @default.
• W2600620731 hasRelatedWork W2418828762 @default.
• W2600620731 hasRelatedWork W2421901264 @default.
• W2600620731 hasRelatedWork W2468273179 @default.
• W2600620731 hasRelatedWork W2626906571 @default.
• W2600620731 hasRelatedWork W2735507005 @default.
• W2600620731 hasRelatedWork W2743220296 @default.
• W2600620731 hasRelatedWork W3013550330 @default.
• W2600620731 hasRelatedWork W3083543475 @default.
• W2600620731 hasRelatedWork W830732586 @default.
• W2600620731 hasRelatedWork W2184577682 @default.
• W2600620731 isParatext "false" @default.
• W2600620731 isRetracted "false" @default.
• W2600620731 magId "2600620731" @default.
• W2600620731 workType "article" @default.